Annotation Detail

Information
Associated Genes
TSC2
Associated Variants
TSC2 p.Ser1079Ter (p.S1079*) ( ENST00000642365.2, ENST00000646388.1, ENST00000439673.6, ENST00000644043.1, ENST00000382538.10, ENST00000642797.1, ENST00000350773.9, ENST00000645186.2, ENST00000642936.1, ENST00000219476.9, ENST00000643946.1, ENST00000644335.1, ENST00000642206.2, ENST00000644329.1, ENST00000643088.1, ENST00000401874.7, ENST00000642561.1, ENST00000568454.6 )
TSC2 p.Ser1079Ter (p.S1079*) ( ENST00000219476.9, ENST00000350773.9, ENST00000382538.10, ENST00000401874.7, ENST00000439673.6, ENST00000568454.6, ENST00000642206.2, ENST00000642365.2, ENST00000642561.1, ENST00000642797.1, ENST00000642936.1, ENST00000643088.1, ENST00000643946.1, ENST00000644043.1, ENST00000644329.1, ENST00000644335.1, ENST00000645186.2, ENST00000646388.1 )
Associated Disease
Isolated focal cortical dysplasia type II tuberous sclerosis 2 Lymphangiomyomatosis
Source Database
ClinVar
Description
NM_000548.5(TSC2):c.3236C>A (p.Ser1079Ter) AND multiple conditions
ClinVar Allele ID
76048
ClinVar RefSeq Alternation Syntax
NM_001114382.3:c.3236C>A
ClinVar RefSeq Alternation Syntax
NM_001370404.1:c.3104C>A
ClinVar RefSeq Alternation Syntax
NM_001318832.2:c.3137C>A
ClinVar RefSeq Alternation Syntax
NM_001077183.3:c.3104C>A
ClinVar RefSeq Alternation Syntax
NM_001318831.2:c.2504C>A
ClinVar RefSeq Alternation Syntax
NM_001363528.2:c.3107C>A
ClinVar RefSeq Alternation Syntax
NM_021055.3:c.3107C>A
ClinVar RefSeq Alternation Syntax
NM_001318829.2:c.2960C>A
ClinVar RefSeq Alternation Syntax
NM_001370405.1:c.3107C>A
ClinVar RefSeq Alternation Syntax
NM_000548.5:c.3236C>A
ClinVar RefSeq Alternation Syntax
NM_001318827.2:c.2996C>A
Clinical Significance Description
Likely pathogenic
Clinical Significance Last Update
2021-08-16
Clinical Significance Review Status
criteria provided, single submitter
URL
https://www.ncbi.nlm.nih.gov/clinvar/RCV002496738
ClinVar Disease
Tuberous sclerosis 2
ClinVar Disease
Lymphangiomyomatosis
ClinVar Disease
Isolated focal cortical dysplasia type II
Observed Origin Sample
unknown
Drugs